NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 years

The NTAGI’s Standing Technical Sub-Committee (STSC) approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday.

However, there was no decision on introducing these vaccines in the vaccination programme.

Data of Biological E’s Corbevax and Bharat Biotech’s Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16…